|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities | |||||
| Net loss | |||||
| Depreciation and amortization expense | |||||
| Non-cash lease expense | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation and amortization expense | |||||
| Impairment of long-lived assets | |||||
| Non-cash lease expense | |||||
| Stock-based compensation expense | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of earnout liability | |||||
| Loss on disposal of property and equipment | |||||
| Offering costs recognized in other expense, net | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Other receivables | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease liability | |||||
| Other non-current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows provided by (used in) investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Payment of Reverse Recapitalization related expenses | |||||
| Proceeds from issuance of common stock through ATM and underwritten offerings, net | |||||
| Proceeds from issuance of common stock through ATM offering, net | |||||
| Proceeds from issuance of common stock and warrants through underwritten offering, net | |||||
| Proceeds from exercise of common stock options | |||||
| Taxes withheld and paid related to net settlement of equity awards | |||||
| Proceeds from issuance of common stock pursuant to Employee Stock Purchase Plan | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the year | |||||
| Cash, cash equivalents and restricted cash at end of the year | |||||
| Supplemental and non-cash items reconciliations: | |||||
| Reclassification of common stock warrant liability into additional paid-in capital | |||||
| Right-of-use asset obtained in exchange for lease liabilities | |||||
| Warrant liability recognized in connection with underwritten offering | |||||
Loading...